prevalence of defining malignancies in adult patients with hiv/aids in the national cancer institute of colombia. 2007-2014

Clicks: 246
ID: 211322
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #35 of 320 articles by views in european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 320 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Introduction: The widespread use of antiretroviral therapy has increased the survival rates of patients infected with human immunodeficiency virus (HIV) and, in consequence, the prevalence of both defining and non-defining cancers. In Colombia, information in this regard is unknown. Objective: To determine the prevalence of defining malignancies in adult patients with HIV treated at the National Cancer Institute over a seven-year period. Materials and methods: Descriptive study involving adult patients diagnosed with HIV and cancer. Sociodemographic variables, CD4 count, viral load and antiretroviral therapy were analyzed by establishing association measures with the presence of defining malignancies. Results: 139 patients with confirmed HIV and cancer diagnosis were found; 84.2% were men. The age range was between 18 and 71 years, with a mean of 41.3±10.9 years. Defining cancers corresponded to 65.5% of the cases, the most frequent being non-Hodgkin lymphoma. The remaining percentage corresponded to non-defining cancers, mainly anal cancer and Hodgkin’s lymphoma. Conclusion: Despite the global trend, the population studied here shows predominance of defining cancers, which, like HIV, continue to be detected at a late stage.
Reference Key
lvarez-guevara2017revistaprevalence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Deisy Álvarez-Guevara;Sonia Cuervo-Maldonado;Ricardo Sánchez;Julio Gómez-Rincón;Nancy Ramírez
Journal european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)
Year 2017
DOI
10.15446/revfacmed.v65n3.56112
URL
https://revistas.unal.edu.co/index.php/revfacmed/article/view/56112
Keywords
hiv highly active antiretroviral therapy acquired immunodeficiency syndrome

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.